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After unleash of the transformation scheme towards China’s healthcare system, 
the road of progress is swamped by difficulties and circumstances are even getting 
dramatically complicated recently. Unstoppable updating philosophy in enterprise 
management, especially in transformation of methodology of marketing, are eagerly 
required for up taking transient opportunities in today’s rapid evolving environment. This 
article aims to systematically analyze and demonstrate methodologies undertaken in 
the marketing system reform scheme, unleashed in first years of mobile internet era 
and the national healthcare system transformation, towards product A, a prescription 
drug launched in 10 years ago.  
Based on factual evidence sums up from data and investigation results published by 
domestic leading institutions in healthcare industry, and combining with personal research 
and understand on core policies in the fresh national healthcare system and latest trends of 
pharmaceutical industry evolution in internet era, this article aims to critically analyze and 
demonstrate critical advantages, key issues, upcoming challenges and progressive plans 
through segmentation the positioning strategy and marketing situation of Product A.    
To be in line with the macro prospects of the national healthcare reform scheme, 
and for construct concrete basement for Product A’s continuous growth, critical 
thoughts   need to be put in fields like satisfaction demands of clients by 
transforming marketing strategy, channel strategy, promoting strategy; buildup and 
optimizing communication mode, service mode, and broadcast mode under mobile 
media age; integration of internal resources and information flow.  
This article spreads into eight chapters; topic and core content are stated as 
follow: 
The 1st Chapter:  
The history of China’s Transformation Scheme of Healthcare System and 
Analysis of its operation,  
An overview on the 35-year national healthcare system reform history and 
demonstration of pharmaceutical industry operational data in the latest 5 years. 
The 2nd Chapter:  













 Review the undergoing Changes and Trends, from perspectives of 
Pharmaceutical Industry, Doctors and Patients in the emerging Internet era 
The 3rd Chapter: Status Analysis of Marketing for Prescription Drug Domestic  
Statement of general situation of the main 4 means for marketing prescription 
drug in China, and the 4P Analysis model. 
The 4th Chapter: Status of marketing Product A 
Description of the framework and marketing strategy of Product A from Eight 
Dimensions 
The 5th Chapter: Marketing Reform Scheme of Product A 
The Reform Scheme applied in client service, evolving market dynamics and 
internal operation for being in line with the national healthcare reform and internet 
normalcy.    
The 6th Chapter: Risks, Challenges and Outlook:  
The Overview on Risk Analysis and Control in product and enterprise revolution. 
The 7th Chapter: Conclusion 
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